Myung In Pharmaceutical LTD. (KRX:317450)

KRX:317450 Revenue

Myung In Pharmaceutical LTD. had revenue of 72.14B KRW in the quarter ending March 31, 2026, with 5.86% growth. This brings the company's revenue in the last twelve months to 289.14B, up 5.51% year-over-year. In the year 2025, Myung In Pharmaceutical LTD. had annual revenue of 287.25B with 6.61% growth.

• Revenue (ttm): 289.14B
• Revenue Growth: +5.51%
• P/S Ratio: 2.21
• Revenue / Employee: 863.09M
• Employees: 335
• Market Cap: 639.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	287.25B	17.82B	6.61%
Dec 31, 2024	269.43B	27.10B	11.18%
Dec 31, 2023	242.34B	16.51B	7.31%
Dec 31, 2022	225.83B	16.58B	7.92%
Dec 31, 2021	209.25B	21.41B	11.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error